Impact Of Diabetic Population Growth On The Liraglutide Market: Critical Driver Shaping the Liraglutide Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Liraglutide Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for liraglutide has seen substantial growth in recent years. The market size, which is expected to be at $6.38 billion in 2024, is projected to inflate to $6.95 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.0%. This growth during the historical period can be credited to the rising prevalence of type 2 diabetes, increasing rates of obesity, numerous clinical trials, greater awareness around diabetes-related health risks, and advancements in medication delivery systems.

Liraglutide Market Size Forecast: What's the Projected Valuation by 2029?
The market for liraglutide is anticipated to experience significant expansion in the coming years, anticipated to reach $9.66 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 8.6%. The surge expected during the forecast period can be related to the growth in insurance and reimbursement policies, advancements in healthcare facilities, rising knowledge and educational programs, an increasing elderly population, and a rise in diabetes cases. The forecast period also notes major advancements including the application of artificial intelligence and machine learning, the need for wearable technology, the integration of continuous glucose monitoring, advancements in biotechnology, and the emergence of digital health platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

What Are the Drivers Transforming the Liraglutide Market?
The growth of the liraglutide market is likely to be propelled by the rising Diabetic population. Diabetes, a chronic condition which is characterized by the body's inability to regulate blood sugar levels adequately due to either inefficient insulin use or insufficient insulin production, sees its incidence grow due to factors like unhealthy diets, sedentary lifestyles, and escalating obesity rates across the globe. Liraglutide, a diabetes medication, aids in the management of type 2 diabetes by simulating the hormone GLP-1, which promotes weight loss, enhances insulin secretion, and reduces blood sugar levels. For instance, a UK-based information website reported in March 2024, that according to the UK Government, the percentage of type 1 diabetes patients in England receiving all eight care processes at GP practices involved in the NDA had risen to 43.8% in March 2023, up from 35.2% in the previous year. Hence, the burgeoning diabetic population is fuelling the expansion of the liraglutide market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

What Long-Term Trends Will Define the Future of the Liraglutide Market?
Key players in the liraglutide market are innovating with products like generic GLP-1 to broaden treatment varieties and fulfil the market need for cheaper alternatives. Generic GLP-1 denotes versions of GLP-1 receptor agonists produced after original branded medications' patent expiration, providing cost-friendly substitutes for managing conditions such as type 2 diabetes and obesity. For example, in June 2024, the Israel-based firm, Teva Pharmaceutical Industries Ltd., launched the first generic GLP-1, modelled after Victoza, in the U.S. market, catering to the growing demand for such treatments. Liraglutide injections are recommended for improving blood sugar regulation in adults and children aged 10 and older with type 2 diabetes and to minimize chances of cardiovascular incidents in adults with type 2 diabetes and pre-existing cardiovascular diseases.

Which Segments in the Liraglutide Market Offer the Most Profit Potential?
The liraglutide market covered in this report is segmented -

1) By Brands: Victoza, Saxenda
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies
3) By Type Of Application: Diabetes Treatment, Weight Management
4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:
1) By Victoza: Type 2 Diabetes Treatment Or Weight Management
2) By Saxenda: Weight Loss Treatment Or Obesity Management

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18659&type=smp

Which Firms Dominate the Liraglutide Market by Market Share and Revenue in 2025?
Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

Which Regions Offer the Highest Growth Potential in the Liraglutide Market?
North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18659

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.